Abstract:As one of the most serious public health problems that extract a high toll on individuals and the society as a whole,substance abuse/addiction has attracted much attention from both researchers and the public.According to the DSM-5,substance addiction is a chronically relapsing psychiatric disorder that has been characterized by compulsion to seek and use drugs,loss of control in limiting intake despite serious negative consequences.However,more than 80％ of the individuals with addiction fall to seek treatment,perhaps reflecting their cognitive function impairments.Previous studies have showed that most drugs of abuse exert their reinforcing effects and produce euphoria by inducing dopamine surges in limbic regions,which then have cascading effects on other neurotransmitter systems,leading to characteristic plastic adaptions;significant changes in neural circuits implicated in reward,attention,inhibitory control,decision making and interoception;and cognitive dysfunctions.However,much is still to be learned about the neural mechanisms involved in drugs' effects on cognitive functions and the vicious cycle of "drug abuse-withdrawal-recovery-relapse".For a better understanding of the causes of substance addiction and its underlying neural mechanisms,we provide an integrative review of behavioral and neuroimaging studies in substance addiction,introduce a neurobiological model of substance addiction,and finally propose future directions for research and clinical treatment.First,we summarize the research on the cognitive and neural mechanisms involved in substance addiction.(1) Drug-related cues can enhance the activities in the mesocorticolimbic system implicated in reward and drug motivation,which then result in increased attention to the drug-related stimuli.Thus,the neural changes in the frontolimbic system may be a potential neural basis for attentional bias toward drugs in individuals with addiction.(2) The deficit in inhibitory control typically observed in individuals with substance addiction may be due to a dysfunction in their prefrontal cortex-striatothalamic circuitry.(3) These individuals' poor decision making may be a product of an imbalance between three separate,but interacting,neural systems:the amygdala-striatum (an impulsive system);the prefrontal cortex (a reflective system);and the insula (the interoceptive system).(4) Emerging evidence shows that individuals with drug addiction have interoceptive processing deficits,perhaps due to dysfunctions in brain systems such as the insula and the anterior cingulate cortex.Second,we introduce a neurobiological model of substance addiction that depicts addiction as a result of an imbalance of six interactive circuits (i.e.,reward,motivation/drive,memory,executive control,mood,and interoception).These brain circuits interact with one another to attain proper inhibitory control and hence good decision making.During addiction,however,the enhanced activities of six circuits (i.e.,reward,motivation,memory,executive control,mood,and interoception) overwhelm the PFC's inhibitory control and hence lead to craving.Finally,we propose that future studies should (1) use multi-modal imaging techniques,(2) pay attention to comorbidity and clarify the association between addiction and other psychiatric disorders,(3) discover more biomarkers and optimize the diagnostic system using both behavioral and neuroimaging information,and (4) develop brain-based intervention techniques.Such studies should deepen our understanding of substance addiction and provide insights to its treatment.

A transdiagnostic dimensional approach towards a neuropsychological assessment for addiction: an international Delphi consensus study

Addictions Neuroclinical Assessment: A Neuroscience-Based Framework for Addictive Disorders

Proposing an integrative, dynamic and transdiagnostic model for addictions: dysregulation phenomena of the three main modes of the predostatic mind

A Roadmap for Integrating Neuroscience Into Addiction Treatment: A Consensus of the Neuroscience Interest Group of the International Society of Addiction Medicine

Cognitive Dysfunction in the Addictions (CDiA): A Neuron to Neighbourhood Collaborative Research Program on Executive Dysfunction and Functional Outcomes in Outpatients Seeking Treatment for Addiction

A Novel, Expert-Endorsed, Neurocognitive Digital Assessment Tool for Addictive Disorders: Development and Validation Study

Cognitive training and remediation interventions for substance use disorders: a Delphi consensus study

How can we conceptualize behavioural addiction without pathologizing common behaviours?

Neurobiology, psychotherapeutic interventions, and emerging therapies in addiction: a systematic review

Testing the transdiagnostic hypothesis of inhibitory control deficits in addictions: An experimental study on gambling disorder

Overlapping dimensional phenotypes of impulsivity and compulsivity explain co-occurrence of addictive and related behaviors

An International, Multidisciplinary Consensus Set of Patient-Centered Outcome Measures for Substance-Related and Addictive Disorders

Addiction as a brain disease revised: why it still matters, and the need for consilience

Neuromarkers in addiction: definitions, development strategies, and recent advances

Parameter Space and Potential for Biomarker Development in 25 Years of Fmri Drug Cue Reactivity

Cognitive dysfunction and underlying neural basis in substance addiction

The ReCoDe addiction research consortium: Losing and regaining control over drug intake-Findings and future perspectives

A methodological checklist for fMRI drug cue reactivity studies: development and expert consensus

Dopamine D2/3 receptor availability in alcohol use disorder and individuals at high risk: Towards a dimensional approach

Neuroimaging Biomarkers in Addiction

Pathways from Epigenomics and Glycobiology Towards Novel Biomarkers of Addiction and Its Radical Cure.